Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | glycoprotein hormones, alpha polypeptide | Starlite/ChEMBL | No references |
Homo sapiens | glucosidase, alpha | Starlite/ChEMBL | No references |
Homo sapiens | muscleblind-like splicing regulator 1 | Starlite/ChEMBL | No references |
Homo sapiens | aldehyde dehydrogenase 1 family, member A1 | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Mycobacterium tuberculosis | Succinate-semialdehyde dehydrogenase [NADP+] dependent (SSDH) GabD1 | aldehyde dehydrogenase 1 family, member A1 | 501 aa | 456 aa | 33.3 % |
Toxoplasma gondii | intraflagellar transport protein 172, putative | glycoprotein hormones, alpha polypeptide | 116 aa | 94 aa | 26.6 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Loa Loa (eye worm) | glutathione reductase | 0.0126 | 0.5352 | 0.5347 |
Trichomonas vaginalis | maltase-glucoamylase, putative | 0.0044 | 0.0011 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.018 | 0.8933 | 0.8932 |
Leishmania major | alpha glucosidase II subunit, putative | 0.0044 | 0.0011 | 0.002 |
Mycobacterium tuberculosis | Probable aldehyde dehydrogenase | 0.0073 | 0.1947 | 0.3637 |
Mycobacterium tuberculosis | NADPH-dependent mycothiol reductase Mtr | 0.0126 | 0.5352 | 1 |
Toxoplasma gondii | thioredoxin reductase | 0.0126 | 0.5352 | 1 |
Trypanosoma brucei | trypanothione reductase | 0.0126 | 0.5352 | 1 |
Mycobacterium leprae | DIHYDROLIPOAMIDE DEHYDROGENASE LPD (LIPOAMIDE REDUCTASE (NADH)) (LIPOYL DEHYDROGENASE) (DIHYDROLIPOYL DEHYDROGENASE) (DIAPHORASE | 0.0043 | 0 | 0.5 |
Trichomonas vaginalis | alpha-glucosidase, putative | 0.0044 | 0.0011 | 1 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0044 | 0.0011 | 0.002 |
Echinococcus multilocularis | muscleblind protein | 0.018 | 0.8933 | 0.8933 |
Trypanosoma brucei | glucosidase, putative | 0.0044 | 0.0011 | 0.002 |
Brugia malayi | Glycosyl hydrolases family 31 protein | 0.0044 | 0.0011 | 0.0011 |
Loa Loa (eye worm) | thioredoxin reductase | 0.0126 | 0.5352 | 0.5347 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0044 | 0.0011 | 0.002 |
Treponema pallidum | NADH oxidase | 0.0043 | 0 | 0.5 |
Schistosoma mansoni | alpha-glucosidase | 0.0169 | 0.8212 | 1 |
Plasmodium vivax | glutathione reductase, putative | 0.0126 | 0.5352 | 1 |
Brugia malayi | Thioredoxin reductase | 0.0126 | 0.5352 | 0.5352 |
Loa Loa (eye worm) | glycosyl hydrolase family 31 protein | 0.0197 | 1 | 1 |
Trypanosoma cruzi | trypanothione reductase, putative | 0.0126 | 0.5352 | 1 |
Mycobacterium ulcerans | aldehyde dehydrogenase | 0.0073 | 0.1947 | 1 |
Leishmania major | aldehyde dehydrogenase, mitochondrial precursor | 0.0073 | 0.1947 | 0.3637 |
Entamoeba histolytica | glycosyl hydrolase, family 31 protein | 0.0044 | 0.0011 | 0.5 |
Giardia lamblia | NADH oxidase lateral transfer candidate | 0.0043 | 0 | 0.5 |
Toxoplasma gondii | glycosyl hydrolase, family 31 protein | 0.0044 | 0.0011 | 0.002 |
Mycobacterium ulcerans | aldehyde dehydrogenase | 0.0073 | 0.1947 | 1 |
Plasmodium vivax | thioredoxin reductase, putative | 0.0126 | 0.5352 | 1 |
Trichomonas vaginalis | alpha-glucosidase, putative | 0.0044 | 0.0011 | 1 |
Echinococcus multilocularis | thioredoxin glutathione reductase | 0.0126 | 0.5352 | 0.5352 |
Entamoeba histolytica | glycosyl hydrolase, family 31 protein | 0.0044 | 0.0011 | 0.5 |
Leishmania major | trypanothione reductase | 0.0126 | 0.5352 | 1 |
Trichomonas vaginalis | sucrase-isomaltase, putative | 0.0044 | 0.0011 | 1 |
Toxoplasma gondii | aldehyde dehydrogenase | 0.0073 | 0.1947 | 0.3637 |
Wolbachia endosymbiont of Brugia malayi | dihydrolipoamide dehydrogenase E3 component | 0.0043 | 0 | 0.5 |
Trichomonas vaginalis | neutral alpha-glucosidase ab precursor, putative | 0.0044 | 0.0011 | 1 |
Brugia malayi | Muscleblind-like protein | 0.018 | 0.8933 | 0.8933 |
Echinococcus multilocularis | lysosomal alpha glucosidase | 0.0197 | 1 | 1 |
Echinococcus granulosus | lysosomal alpha glucosidase | 0.0197 | 1 | 1 |
Schistosoma mansoni | aldehyde dehydrogenase | 0.0073 | 0.1947 | 0.237 |
Plasmodium falciparum | thioredoxin reductase | 0.0126 | 0.5352 | 1 |
Schistosoma mansoni | alpha glucosidase | 0.0044 | 0.0011 | 0.0013 |
Echinococcus granulosus | neutral alpha glucosidase AB | 0.0044 | 0.0011 | 0.0011 |
Echinococcus granulosus | thioredoxin glutathione reductase | 0.0126 | 0.5352 | 0.5352 |
Trichomonas vaginalis | alpha-glucosidase, putative | 0.0044 | 0.0011 | 1 |
Trichomonas vaginalis | neutral alpha-glucosidase ab precursor, putative | 0.0044 | 0.0011 | 1 |
Echinococcus multilocularis | aldehyde dehydrogenase, mitochondrial | 0.0073 | 0.1947 | 0.1947 |
Schistosoma mansoni | aldehyde dehydrogenase | 0.0073 | 0.1947 | 0.237 |
Echinococcus multilocularis | muscleblind protein 1 | 0.018 | 0.8933 | 0.8933 |
Chlamydia trachomatis | dihydrolipoyl dehydrogenase | 0.0043 | 0 | 0.5 |
Trichomonas vaginalis | alpha-glucosidase, putative | 0.0044 | 0.0011 | 1 |
Schistosoma mansoni | alpha-glucosidase | 0.0169 | 0.8212 | 1 |
Echinococcus multilocularis | lysosomal alpha glucosidase | 0.0197 | 1 | 1 |
Onchocerca volvulus | 0.0114 | 0.4587 | 0.5 | |
Echinococcus granulosus | muscleblind protein | 0.018 | 0.8933 | 0.8933 |
Plasmodium falciparum | glutathione reductase | 0.0126 | 0.5352 | 1 |
Echinococcus multilocularis | neutral alpha glucosidase AB | 0.0044 | 0.0011 | 0.0011 |
Wolbachia endosymbiont of Brugia malayi | dihydrolipoamide dehydrogenase E3 component | 0.0043 | 0 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.018 | 0.8933 | 0.8932 |
Echinococcus granulosus | aldehyde dehydrogenase mitochondrial | 0.0073 | 0.1947 | 0.1947 |
Trichomonas vaginalis | alpha-glucosidase, putative | 0.0044 | 0.0011 | 1 |
Brugia malayi | glutathione reductase | 0.0126 | 0.5352 | 0.5352 |
Mycobacterium ulcerans | aldehyde dehydrogenase | 0.0073 | 0.1947 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 1.9953 uM | PubChem BioAssay. qHTS for Activators of Integrin-Mediated Alleviation for Muscular Dystrophy. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 2.2387 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1). (Class of assay: confirmatory) [Related pubchem assays: 1030 (qHTS Validation Assay for Inhibitors of aldehyde dehydrogenase 1 (ALDH1A1))] | ChEMBL. | No reference |
Potency (functional) | 7.3753 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | = 7.9433 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase Cleavage of Glycogen. (Class of assay: confirmatory) [Related pubchem assays: 1473, 1466 ] | ChEMBL. | No reference |
Potency (functional) | 10.4179 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (binding) | 14.1254 uM | PubChem BioAssay. qHTS Assay for Inhibitors of MBNL1-poly(CUG) RNA binding. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 25.1189 uM | PubChem BioAssay. qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1). (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 50.1187 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623] | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Plasmodium falciparum | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.